Publications by authors named "Henia Balter"

Claim this Profile
O
Oxidant and Antioxidant Effects of Gentisic Acid in a Lu-Labelled Methionine-Containing Minigastrin Analogue.
Victoria Trindade, Henia Balter

Curr Radiopharm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ga-PSMA and C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle.
Omar Alonso, Gerardo Dos Santos, Margarita García Fontes, Henia Balter, Henry Engler

Eur J Hybrid Imaging· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An optimized clarithromycin-free 14-day triple therapy for Helicobacter pylori eradication achieves high cure rates in Uruguay.
Cristina Dacoll, Jordi Sánchez-Delgado, Henia Balter, Ximena Pazos, María Di Pace

Gastroenterol Hepatol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
¹⁷⁷Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay.
Henia Balter, Trindade Victoria, Terán Mariella, Gaudiano Javier, Ferrando Rodolfo

Curr Radiopharm· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
⁶⁸Ga-NOTA-UBI-29-41 as a PET Tracer for Detection of Bacterial Infection.
Mónica Vilche, Ana Laura Reyes, Elena Vasilskis, Patricia Oliver, Henia Balter

J Nucl Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Evolution of the response to the first-line therapy for Helicobacter pylori infection in Uruguay].
Cristina Dacoll, Henia Balter, Laura Varela, Gaby Buenavida, Nicolás González

Acta Gastroenterol Latinoam· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potencial theranostic agent for EGF-R expression tumors: (177)Lu-DOTA-nimotuzumab.
Victoria Calzada, Xiuli Zhang, Marcelo Fernandez, Arlhee Diaz-Miqueli, Normando Iznaga-Escobar, Henia Balter

Curr Radiopharm· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[177Lu]DOTA-anti-CD20: labeling and pre-clinical studies.
Paola F Audicio, Gustavo Castellano, Marcos R Tassano, Maria E Rezzano, Marcelo Fernandez, Henia Balter

Appl Radiat Isot· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M cells prefer archaeosomes: an in vitro/in vivo snapshot upon oral gavage in rats.
Maria Jose Morilla, Diego Mengual Gomez, Pablo Cabral, Mirel Cabrera, Henia Balter

Curr Drug Deliv· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-site interaction evaluation of Tn density by inhibition/competition assays.
Ana Robles, Andrea Medeiros, Nora Berois, Henia S Balter, Ernest K Pauwels

Nucl Med Biol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies against the Tn-specific isolectin B4 from Vicia villosa seeds: characterization of the epitope of the blocking antibody VV34.
Andrea Medeiros, Nora Berois, Henia Balter, Ana Robles, Enrique Perez-Payá

Hybrid Hybridomics· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Labeling and quality control of 188Re-lanreotide.
Silvia Verdera, Henia Balter, Graciela Rodríguez, Patricia Oliver, Beatriz Souto

Cell Mol Biol (Noisy-le-grand)· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiochemical and biological characteristics of 99mTc-UBI 29-41 for imaging of bacterial infections.
Mick M Welling, Sandra Mongera, Antonella Lupetti, Henia S Balter, Valeria Bonetto

Nucl Med Biol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose.
Eduardo Savio, Javier Gaudiano, Ana M Robles, Henia Balter, Andrea Paolino

BMC Nucl Med· January 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis